[Skip to Content]
[Skip to Content Landing]
Article
May 12, 1969

Evaluation of a Hypocholesterolemic AgentDextrothyroxine Sodium (Choloxin)

JAMA. 1969;208(6):1014-1015. doi:10.1001/jama.1969.03160060084012
Abstract

Dextrothyroxine sodium lowers the level of serum cholesterol in most euthyroid patients. Untoward effects due to the metabolic action of this agent, which usually can be avoided by careful adjustment of dosage, include increased frequency or severity of anginal attacks, cardiac arrhythmias, nervousness, insomnia, and hyperthermia.

×